OOIR: Observatory of International Research

Papers

(The TQCC of Rheumatic Disease Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Racial/Ethnic, Socioeconomic, and Geographic Disparities in the Epidemiology of Knee and Hip Osteoarthritis	57
Rheumatoid Arthritis	45
Treatment Guidelines in Rheumatoid Arthritis	41
Osteoarthritis Treatment Guidelines from Six Professional Societies	35
Racial/Ethnic and Socioeconomic Disparities in Osteoarthritis Management	33
Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis	28
Understanding Lupus Disparities Through a Social Determinants of Health Framework	26
Basic Mechanisms of Pain in Osteoarthritis	26
Gender and Ethnic Inequities in Gout Burden and Management	24
B Cells in Systemic Lupus Erythematosus	22
Systemic Lupus Erythematosus Classification and Diagnosis	19
Disparities in Lupus and Lupus Nephritis Care and Outcomes Among US Medicaid Beneficiaries	19
Socioeconomic Status, Health Care, and Outcomes in Systemic Lupus Erythematosus	18
COVID-19 in Pediatrics	17
Low Back Pain in Adolescent and Geriatric Populations	16
Uveitis in Children and Adolescents	15
Recent Updates in Juvenile Spondyloarthritis	15
Juvenile Localized Scleroderma	15
Racial Disparities in Systemic Sclerosis	15
Racial Disparities in Rheumatology Through the Lens of Critical Race Theory	14
Health Disparities in Systemic Lupus Erythematosus	14
Neutrophil Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus	14
Targeting Nerve Growth Factor for Pain Management in Osteoarthritis—Clinical Efficacy and Safety	14
Use of Quality Measures to Identify Disparities in Health Care for Systemic Lupus Erythematosus	13
T Cells in Systemic Lupus Erythematosus	12

Environmental Triggers of Hyperuricemia and Gout	12
Treatment Update in Systemic Lupus Erythematous	12
Updates on Juvenile Dermatomyositis from the Last Decade: Classification to Outcomes	12
Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus	11
Behçet Syndrome	11
Juvenile Idiopathic Arthritis Treatment Updates	11
Disparities in Rheumatoid Arthritis Care and Health Service Solutions to Equity	11
The Meaningful Role of Patients, and Other Stakeholders in Clinical Practice Guideline Development	10
Management of Pregnancy in Lupus	10
Interferons in Systemic Lupus Erythematosus	10
The Power of Systems Biology	10
Mental Health in Pediatric Rheumatology	9
Understanding Risk Factors for Poor Outcomes in a Multiethnic Longitudinal Cohort	8
Giant Cell Arteritis and Polymyalgia Rheumatica	8
Understanding the Disproportionate Burden of Rheumatic Diseases in Indigenous North American Populations	8
The Contribution of Genetics and Epigenetics to Our Understanding of Health Disparities in Rheumatic Diseases	8
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk	8
Unique Aspects of Pediatric Sjögren Disease	8
Recommendations for Systemic Lupus Erythematosus	8
Systemic Autoinflammatory Diseases	8
Health Disparities in Rheumatic Diseases	8
Pain in Axial Spondyloarthritis	8
Pain Mechanisms in Patients with Rheumatic Diseases	8
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury	8
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	8
How the American College of Rheumatology Develops Guidelines	8
Chronic Nonbacterial Osteomyelitis	8
The Categorization of Pain in Systemic Lupus Erythematosus	8
Treatment Guidelines in Gout	8
Management and Cure of Gouty Arthritis	8
The Temporomandibular Joint in Juvenile Idiopathic Arthritis	8
Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma	7
Designing an Intervention to Improve Management of High-Risk Lupus Patients Through Care Coordination	7
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis	7
Why It Hurts	7
Disparities in Childhood-Onset Lupus	7
Disparities in Pediatric Rheumatic Diseases	7
Environmental Risks for Spondyloarthropathies	6
Atherosclerotic Cardiovascular Risk Stratification in the Rheumatic Diseases:	6
Ultrasonography in Pediatric Rheumatology	6
Leveraging Telemedicine as an Approach to Address Rheumatic Disease Health Disparities	6
Treatment of Inflammatory Arthritis in Systemic Sclerosis	6
Treatment Guidelines in Vasculitis	6
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis	5
Pharmacosurveillance in Juvenile Idiopathic Arthritis	5
Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy	5
Nonpharmacologic Pain Management in Inflammatory Arthritis	5
Fibromyalgia	5
Systemic Lupus Erythematosus Outcome Measures for Systemic Lupus Erythematosus Clinical Trials	5
Instrumental Substance Use Among Youth with Rheumatic Disease—A Biopsychosocial Model	5

Juvenile Fibromyalgia	5
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis	5
Gastrointestinal Tract Considerations Part I	5
Sexual Dimorphism in the Expression of Pain Phenotype in Preclinical Models of Rheumatoid Arthritis	5
Pediatric Rheumatic Disease in Lower to Middle-Income Countries	5
Patient Engagement in Pediatric Rheumatology Research	5
Systemic Lupus Erythematosus Risk	5
The GRADE Method	4
Cardiovascular Health in Pediatric Rheumatologic Diseases	4
Management of Knee Osteoarthritis	4
Venous Thromboembolism in the Inflammatory Rheumatic Diseases	4
Biomarkers in Childhood-Onset Systemic Lupus Erythematosus	4
The Promises and Perils of Social Media for Pediatric Rheumatology	4
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease	4
Implementation Science in Pediatric Rheumatology: A Path to Health Equity	4